tci Medicare Compliance & Reimbursement - 2007 Issue 19
CODING: New Codes Will Distinguish Between Disease- And Drug-Related Diabetes
Subscribe or sign in to view the full article.
Article Overview
This article explains upcoming ICD-9-CM updates discussed by CDC and coding industry representatives, with emphasis on secondary diabetes categories, expanded lymphoma specificity, and additional diagnosis code refinements. It is relevant to coders, compliance staff, and clinical documentation specialists who track annual code updates and specialty-specific diagnosis coding changes.
Why This Topic Matters
The article helps readers understand which diagnosis areas are changing in the ICD-9 update cycle and why those changes matter for more specific documentation and reporting across multiple specialties.
Article Sections
-
Secondary diabetes updates
Discusses the planned addition of new ICD-9 categories for secondary diabetes and the timing of the update process.
-
Lymphoma code expansion
Summarizes new ICD-9 lymphoma coding options and the broader oncology coding context for these changes.
-
Other ICD-9 diagnosis refinements
Covers additional diagnosis code updates affecting swallowing disorders, myotonic conditions, and selected family history or genetic predisposition categories.
What You Will Learn
- How upcoming ICD-9-CM updates affect secondary diabetes coding
- What broad disease areas are receiving expanded diagnosis specificity
- Why certain diagnosis code updates are relevant to oncology and rehabilitation coding
- Which types of family history and genetic predisposition topics are included in the update cycle
Who Should Read This
- Medical coders
- Oncology coders
- Rehabilitation providers
- Clinical documentation specialists
- Coding compliance professionals
Codes Discussed
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com